The present invention comprises compounds of general formula (1)
wherein
A, X, Y, Z, R
a
, R
b
, R
c
, R
1
, R
2
and R
3
are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.